Your browser doesn't support javascript.
loading
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.
Ozkaynak, M Fevzi; Gilman, Andrew L; London, Wendy B; Naranjo, Arlene; Diccianni, Mitchell B; Tenney, Sheena C; Smith, Malcolm; Messer, Karen S; Seeger, Robert; Reynolds, C Patrick; Smith, L Mary; Shulkin, Barry L; Parisi, Marguerite; Maris, John M; Park, Julie R; Sondel, Paul M; Yu, Alice L.
Afiliação
  • Ozkaynak MF; New York Medical College, Valhalla, NY, United States.
  • Gilman AL; Levine Children's Hospital, Charlotte, NC, United States.
  • London WB; Dana Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
  • Naranjo A; Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL, United States.
  • Diccianni MB; Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States.
  • Tenney SC; Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL, United States.
  • Smith M; National Cancer Institute, Bethesda, MD, United States.
  • Messer KS; Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States.
  • Seeger R; Children's Hospital Los Angeles, University Southern California, Los Angeles, Los Angeles, CA, United States.
  • Reynolds CP; Texas Tech University Health Sciences Center, Lubbock, TX, United States.
  • Smith LM; United Therapeutics, Silver Spring, MD, United States.
  • Shulkin BL; St. Jude's Children's Research Hospital, Memphis, TN, United States.
  • Parisi M; Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA, United States.
  • Maris JM; Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Park JR; Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA, United States.
  • Sondel PM; University of Wisconsin Carbone Cancer Center, Madison, WI, United States.
  • Yu AL; Moores Cancer Center, University of California, San Diego, La Jolla, CA, United States.
Front Immunol ; 9: 1355, 2018.
Article em En | MEDLINE | ID: mdl-29967609

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article